The mechanisms of action of most antidepressants are unclear. A study in Nature Medicine now shows that therapeutic concentrations of the antidepressants amitriptyline and fluoxetine reduced the activity of acid sphingomyelinase (ASM), an enzyme that releases ceramide from sphingomyelin, in both cultured neurons and mouse hippocampi. Reducing ceramide levels in the brain had antidepressant effects in mouse models of depression, suggesting that the ASM–ceramide system may be a useful target for new antidepressants.
References
Gulbins, E. et al. Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs. Nature Med. http://dx.doi.org/10.1038/nm.3214 (2013)
Rights and permissions
About this article
Cite this article
Flight, M. A new target for antidepressant drugs. Nat Rev Neurosci 14, 520 (2013). https://doi.org/10.1038/nrn3554
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrn3554